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Abstract 
Aim of novel drug delivery system is to enhance safety and efficacy of drugmolecules by 
formulating a convenient dosage form for administration and to achieve better patient 
compliance. One such approach led to development of fast dissolving tablets. Now-a-days fast 
disintegrating tablets (FDTs) gaining significance with wide variety of drugs serving many 
purposes. These are novel types of tablets that disintegrate/dissolve/ disperse in saliva within few 
seconds (less than 60 seconds) without chewing and additional water. The basic approach used in 
development of FDTs is the use of superdisintegrants and the elimination of bitterness. FDTs 
reduces the disadvantages of conventional dosage form especiallydysphasia (difficulty in 
swallowing) in pediatric and geriatric patients. These oral dosage forms have many benefits such 
as self medication, increased compliance, ease of manufacturing and noninvasive. 
This review presents description of fast dissolving tablets including need for development, 
challenges in formulation, suitability of drug candidates, composition, various technologies 
involved, advantages, disadvantages, and evaluation parameters.  
Keywords-: Fast dissolving tablet, superdisintegrants, and disintegration. 
Introduction 
 The conventional dosage forms (tablets and capsules) have wide range of acceptance up to 50-
60 % of the total dosage forms
1
. Tablet is most popular dosage form of existing forms because of 
ease of self administration, compact in nature, easy to manufactureand it can be delivered in 
accurate dose
2
.  
There is one drawback associated with tablets and that is difficulty in swallowing and chewing in 
some patients particularly in geriatric and pediatric patients. This problem can be avoided by 
means of fast dissolving tablets. One such problem can be solved in the novel drug delivery 
system by formulating “mouth dissolving tablets” which disintegrates or dissolves  
rapidly without water within few seconds in themouth due to the action of superdisintegrant or 
maximizing pore structure in the formulation
3
. 
Fast dissolving tablets are defined as “a solid dosage form containing medicinal substance or 
active ingredient which disintegrates rapidly usually within a matter of seconds when placed 
upon the tongue”. Fast dissolving tablets are especially designed for dysphagia, geriatric, 
pediatric, bed-ridden, travelling and psychotic patients who are unable to swallow or refuse to 
swallow conventional oral formulations. Fast dissolving tablets are also referred as quick 
disintegrating tablets, mouth dissolving tablets, oral rapid disintegratingtablets, rapid dissolving 
tablets, porous tablets and rapid melt tablets
4
.  
The basic approach used in development of FDT is the use of superdisintegrants like ac-di-sol, 
sodium starch glycol ate, kollidon, crospovidone, croscarmellose sodium, l-hydroxypropyl 
cellulose, in a concentration of 1.5 to 7.5%. Superdisintegrants provide instantaneous 
disintegration of tablet, thereby releasing the drug in saliva and absorbed through oral mucosa 
thus drug enters directly into systemic circulation which in turn provides rapid onset of action.  
The fast dissolving drug delivery system are specially designed for the drugs which have 
extensive first pass metabolism and have low dose, for the enhancement ofbioavailability. 
Elimination of bitter taste of drug is an important criterion in the development of mouth 
dissolving tablets
5
.  
Advantages
6, 7, 8
  
 1. Rapid dissolution and absorption of drug. 
2. Avoidance of first pass metabolism. 
3. No need of water to swallow thedosage form. 
4. Ease of administration to patients who have difficulty to swallow a tablet, such as 
pediatric and geriatric patients and psychiatric patients. 
5. Convenience of administration and accurate dosing as compared to liquid formulations. 
6. Bioavailability of hydrophobic and insoluble drugs gets increased due to quicker 
disintegration and dissolution.  
7. Avoidance of risk of choking and suffocation during oraladministration.  
8. New business opportunity like product differentiation, product promotion, patent 
extension and life cycle management. 
Disadvantages
9, 10
  
1. They are fragile and brittle.   
2. FDTs are required to be kept in dry surrounding because of their hygroscopic nature.  
3. It needs special packaging for protection duringstorage and transportation. 
4. The tablets usually have insufficient mechanical strength. Hence, careful handling is 
required during manufacturing process. 
5. The tablets may leave unpleasant taste and/or grittiness in oral cavity if not formulated 
properly. 
6. Drugs with larger doses are difficult to formulate. 
Criteria for fast dissolving tablets
11 
1. Free from bitter taste. 
2. Dose lower than 20 mg. 
3. Small to moderate molecularweight. 
4. Good solubility in water and saliva. 
5. Partially nonionized at the oral cavity's pH. 
6. Ability to permeate oral mucosal tissue. 
Criteria for the selectin of drug
12, 13 
 The ideal characteristics of a drug for fast dissolving tablets include: 
1. Drug should have ability to permeate the oral mucosa. 
2. At least partially non ionized at the oral cavity pH. 
3. Have the ability to diffuse into theepithelium of the upper GIT. 
4. Short half life and frequent dosing drugs are unsuitable for fast dissolving tablets. 
5. Drug should have good stability in saliva and water. 
6. Drugs have very bitter or unacceptable taste and odor is unsuitable for orodispersible 
tablets (ODT). 
 
 
 
 
 
 
 
 
 
 
 
 Excipients used in fast dissolving tablets 
 
Ingredients of fast dissolving tablets 
Table 1: Ingredients of fast dissolving tablets 
Serial 
no. 
Name of 
excipients 
Role of excipient Example 
1. Superdisintegrants
 
To promote moisture penetration and 
disintegration/dispersion of the matrix 
of dosage form in dissolutionfluids. 
These are generally used in a low 
concentration (1-10%)
14
. 
Croscarmellose sodium 
(Ac-Di-Sol), 
Crosspovidone, sodium 
starch glycolate (SSG). 
2. Bulking materials Contributes functions of a diluent, 
filler and cost reducer. These agents 
improve the textural characteristics 
which further enhance the 
disintegration. 
Mannitol, polydextrose, 
lactitol, DCL (direct 
compressible lactose) and 
starch hydrolystate. 
3. Lubricants Remove grittiness and assist in the 
drug transportmechanism from the 
mouth down into the stomach
15
. 
Talc, waxes and 
oils,PEG,stearic acid and 
derivatives, leucine, 
sodium benzoate, talc, 
magnesium lauryl 
sulphate, liquid paraffin. 
4. Flavours and 
Sweetners 
Makes more palatable and pleasing 
products for patients, mask bitterness 
and disagreeable tastes of some active 
ingredients. Both natural and synthetic 
flavors aree used. 
Flavours- Peppermint 
flavour, clove oil, anise 
oil, eucalyptus oil. 
 Sweetners-Sugar, 
dextrose and fructose, 
aspartame, 
sodium saccharin, sugar 
alcohols and sucralose. 
EXCIPIENTS 
1. 
SUPERDISINTEGRANTS 
2. BULKING 
MATERIALS 
3. LUBRICANTS 
4. FLAVOURS 
AND SWEETNERS 
5. EMULSIFYING 
AGENT 
 5. Emulsifying agent They aid in rapid disintegration and 
drug release withoutchewing, 
swallowing or drinking water. They 
also stabilizes the immiscible blends 
and enhances bioavailability
16
. 
Alkyl sulfates, propylene 
glycol esters, lecithin, 
sucrose esters. 
 
Criteria for the selection of super disintegrants
17 
1. Produce rapid disintegration, when tablet comes in contact withsaliva in the mouth/oral 
cavity. 
2. Be compactable enough to produce less friable tablets. 
3. Produce good mouth feel to the patients. Thus, small particle size is preferred to achieve 
patient compliance. 
4. Have good flow, since it improves the flow characteristics of total blend. 
Mechanism of super-disintegrants
18, 19 
The four major mechanisms for tablet disintegration are as following-: 
1. Swelling- When tablet comes in contact with water thenswelling occurs and thus adhesiveness 
of other ingredients of the tablet is lost, causing the tablet disintegration.                                        
2. Porosity and Capillary Action (Wicking) -Due to the porous nature of the tablet, the liquid 
is drawn (wicking action) into the tablet through capillary action, thus the inter-particulate bonds 
get ruptured causing disintegration of tablet.  
3. Deformation-The superdisintegrants get deformed during tabletcompression and upon contact 
with water they regain their normal structure which causes an increase in size of deformed 
particles resulting in the breaking of tablet.  
4. Due to repulsive forces-Another mechanism of disintegration attempts the swelling of tablet 
made with‘nonswellable’ disintegrants.  Nonswelling particle also cause disintegration of tablets. 
Generation of electric repulsive forces between particles promotes the disintegration of tablet and 
water is required for it.  
Conventional techniques used in the preparation of fast dissolving tablets 
 The various techniques used for the preparation offast dissolving tablets are-: 
1. Direct Compression
20
- 
It is considered as the best method to prepare orallydisintegrating dosage forms. The general 
scheme of direct compression is as follows: 
                 Milling→ Sieving → Mixing → Compression 
It is one of the most popular and convenient techniques for the preparation of FDTs. Here the 
FDTs are punched at significantly lower forces (4–10 kN) than the conventional tablets. 
2. Sublimation/ effervescent-  
Rapid disintegration of fast dissolving tablets is due to the presence of a porous structure in tablet 
matrix. Hence to generate porous matrix, volatile ingredientsare used then removed by 
sublimation, leaving behind a porous matrix, were compressed along with other excipients into a 
tablet. 
3. Mass extrusion- 
It involves softening of the active blend using the solvent mixture of water soluble polyethylene 
glycol and methanol and expulsion of softened mass through the extruder or syringe to get a 
 cylindrical shaped extrude which are finally cut into even  segments using heated blade to form 
tablets. 
4. Tablet molding- 
Molding process is of two types i.e. solvent method and heat method. Solvent method involves 
moistening the powder blend with a hydro alcoholic solvent followedby compression at low 
pressures in molded plates to form a wetted mass. The solvent is then removed by air-drying.  
5. Lyophillization / Freeze drying- 
This technique creates an amorphous porous structure that can dissolve rapidly. The active drug 
is dissolved or dispersed in an aqueous solution of a carrier/polymer. The mixture is poured in 
the walls of the preformed blister packs. The trays holding the blister packs are passed through 
liquid nitrogen freezing tunnel to freeze the drug solution or dispersion. Thenthe frozen blister 
packs are placed in refrigerated cabinets to continue the freeze-drying
21
.  
6. Melt granulation- 
 It is a process by which powders are efficiently agglomerated by a meltable binder which can be 
a molten liquid, a solid or a solid that melts during the process. It is used to enhance the 
dissolution rate of poorly water-soluble drugs, such as griseofulvin. Thisapproach is used to 
prepare FDTs with sufficient mechanical integrity. 
7. Nanonization –  
A Nanomelt technology involves size reduction of drug to nanosize by milling the drug using a 
proprietary wet-milling technique. The nanocrystals of the drug are stabilized against 
agglomeration by surface adsorption on selected stabilizers, which are then incorporated into 
FDTs. 
8. Cotton candy process - This process is so named as it utilizes an inimitable spinning 
mechanism to produce floss like crystalline structure, which mimics cotton candy. In this process 
matrix of polysaccharides are formed by simultaneous action of flash melting and spinning. This 
candy floss matrix is then milled and blended with activeingredients and excipients after re-
crystallization and subsequently compressed to FDT
22
. 
9. Three-dimensional printing (3DP) –  
It is a rapid prototyping technology, which involves constructing specific layers that uses powder 
processing and liquid binding materials. 
Important patented technologies for fast dissolving tablets 
1. Zydis Technology  
This is the patented technology of Catalent Pharma solutions. Zydis formulation is a unique 
freeze dried tablet in whichdrug is physically entrapped or 
dissolved within the matrix of fast dissolving carrier material. When zydis units are put into 
the mouth, the freeze-dried structure disintegrates instantaneously and does not require water 
to aid swallowing.  To impart strength and resilience during handling, polymers such as 
gelatin, dextran or alginates are incorporated. These form a glossyamorphous structure, 
which imparts strength. Blister packs are used for Zydis products to protect the formulation from 
moisture present in the environment
23
. 
2. Durasolv Technology  
Durasolv is the patented technology of CIMA labs. Tablets produced by this technology have 
much higher mechanical strength and the production is a faster and effective. The tablets made 
by this technology consist of drug, filler and a lubricant. Tablets areprepared by using 
conventional tabletting equipment and have good rigidity. These can be packaged into 
 conventional packaging system like blisters. Durasolv is an appropriate technology for product 
requiring low amount of active ingredients
24
. 
3. Ziplets Technology  
This technology is patented by Passano con Barnago, Italy. It can be used with water insoluble 
compounds as both bulk actives and as coated microparticles. These tablets are with improved 
mechanical strength and optimal disintegration time at low compression force.  In fact, tablets 
composed primarily of water-soluble components often tend to dissolve rather thandisintegrate, 
resulting in a much longer disintegration time
24
.  
4. Flash Dose Technology  
Flash dose technology has been patented by fuisz. Flash dose tablets consist of self-binding shear 
form matrix termed as “floss”. Shear form matrices are prepared by flash heat processing. 
Nurofen meltlet, a new form of ibuprofen as melt in mouth tablets preparedusing flash dose 
technology is the first commercial product launched by Biovail Corporation
25
.  
5. Flash Tab Technology  
Prographarm laboratories have patented the Flash tab technology. Active ingredient is used in the 
form of micro crystals. Drug micro granules may be prepared by using the conventional 
techniques like coacervation, micro encapsulation andextrusion spheronisation. All the 
processing utilized conventional tabletting technology25. 
6. Novel Hole Technology 
It is developed to minimize the disintegration time and maximize the patient compliance. Tablets 
formulated by this technique usually disintegrate in 10–20 s.In this technology, highly volatile 
ingredients like ammonium bicarbonate, ammonium carbonate, benzoic acid, camphor, 
naphthalene, urea, urethane and phthalic anhydride may be compressed along with other 
excipients into a tablet. These volatile materials are then removed bysublimation creating a 
highly porous matrix. Absolute surface area of the tablet increases due to hole formation. The 
main mechanism involved in whole technology is sublimation.  
7. Oraquick Technology  
The Oraquick fastdissolving/ disintegrating tablet formulation utilizes a patented taste 
masking technology. There is no utilization of solvents to mask taste, thus leads to faster and 
more efficient production.  Since there is lower heat of production thanalternative fast dissolving/ 
disintegrating technologies, so it is appropriate for heat sensitive drugs. Oraquick claims quick 
dissolution in a matter of seconds, with good taste masking24.  
8. Quicksolv Technology  
This technology is patented by Janssen Pharmaceutica, Beese,Belgium. It utilizes two solvents in 
formulating a matrix, which disintegrates instantly. Product formed by thistechnology has 
uniform porosity and adequate strength for handling. Methodology includes dissolving matrix 
components in water and the solution or dispersion is frozen. Then dry the matrix by 
removing water using an excess of alcohol (solvent extraction)
23
.  
9. Lyoc Technology  
Lyoc technology is patented by pharmalyoc. It utilizes a freeze drying process but it differs 
from Zydis in that the product is frozen on the freeze dryer shelves.  Oil in wateremulsion is 
prepared and placed directly into blister cavities followed by freeze-drying. Nonhomogeneity 
during freeze-drying is avoided by incorporating inert filler to increase the viscosity finally the 
sedimentation. High proportion of filler reduces porosity of tablets due to which disintegration is 
lowered. 
10. Pharmabrust Technology 
 Pharmaburst technology is being patented by SPI pharma. Tablet prepared by this technique  
dissolve within 30-40 seconds. The tablet manufactured by this process involves a dryblend of a 
drug, flavors, and lubricant then followed by compression into tablets
26
.   
11. Frosta technology: 
Akina patents this technology. Plastic granules are prepared and compressed at low pressure to 
produce strong tablets with high porosity. Plastic granules composed of porous and plastic 
material, water penetration enhancer, and binder. The process involves mixing the porous plastic 
material with water penetration enhancer followed by granulating with binder. The tablets 
obtained have excellent hardness and rapid disintegration time ranging from 15 to 30 sec 
depending on size of tablet
27
. 
12. Nanocrystal Technology  
This is patented by Elan, King of Prussia. It includes lyophilization of colloidal dispersions of 
drug substance and water-soluble ingredients filled in to blister pockets. This method avoids 
manufacturing process such as granulation, blending, and tableting, which is moreadvantageous 
for highly potent and hazardous
26
. 
13. Wowtab  
Wowtab technology was developed by Yamanouchi Pharma Technologies. “Wow” means 
without water. The active ingredients may constitute up to 50% w/w of the tablet.  
Saccharides of both low and high moldability are used to prepare the granules. Moldability is the 
capacity of a compound to be compressed. Highly Moldable substance has high compressibility 
and thus slow dissolution. The combination of high and low moldability is 
used to produce tablets of adequate hardness and a rapidly melting strongtablet. Wowtab product 
dissolves quicklyin 15 seconds or less
28
.  
Table 2: Commercially available Patented Fast dissolving Technologies 
Patented 
Technology 
Patent Holder  Technology 
Basis 
Active 
Ingredients  
Available 
Products 
 
Advatab  
Eurand 
International, 
Dayton OH 
Direct 
compression 
Cetrizine  
AdvaTab 
Cetrizine 
Durasolv  Cima Labs Inc,  
Direct 
compression 
Zolmitriptane  Zolmig®ZMT 
Flashtab  
Prographarm 
laboratories 
Direct 
compression 
Ibuprofen  
Nurofen®Flash 
Tab 
Flash Dose  
Biovail(Fuisz 
Technology, Ltd) 
Cotton Candy 
Process 
Tramadol HCl  
Relivia 
Flashdose® 
Lyoc  Farmayoc  Freeze-drying  
Phloroglucinol 
hydrate 
Spasfon lyoc 
Orasolv  Cima Labs Inc,  
Direct 
compression 
Mirtazapine  Remeron®SolTab 
Oraquick  
KV 
Pharm.Co.Inc.  
Micromask 
taste masking 
Hyoscyamine 
sulfate  
Hyoscyamine 
sulphate 
ODT 
QuickSolv  
Janssen 
pharmaceutics 
Freeze-drying  
Cisapride 
monohydrate 
Propulsid 
Quicksolv 
Wowtab  
Yamanouchi 
Pharma Tech,Inc 
Direct 
compression 
Famotidine  Gaster D 
Zydus  
R.P.Scherer,Inc 
[Cardinal Health] 
Freeze-drying  Loratidine  Claritin®Reditab 
 Ziplets  
Eurand 
International, 
Dayton OH 
Direct 
compression 
Ibuprofen  Cibalginadue Fast 
Preformulation studies of blends 
1. Bulk density
29
  
Bulk density can be determined by pouring blend into a graduated measuring cylinder using a 
funnel and weigh.The bulk density can be calculated using the formula-: 
Bulk density= (Weight of the powder)/(Bulk volume) 
2. Tapped density
29
-  
Same measuring cylinder should be set for the determination of tapped density that was used for 
the determination of bulk volume. Set measuring cylinder to 300 taps per minute and operate for 
500 taps. The tapped density is calculated by the following formula-: 
Tapped density= (Weight of the powder)/(Tapped volume) 
3. Angle of repose (θ)29 –  
It is an indication of the flow properties of the powder. It is defined as maximum angle possible 
between the surface of the pile of powder and the horizontal plane. The powder mixture is 
allowed to flow through the funnel fixed to a stand at definite height (h). The angle of repose is 
then calculated by measuring the height and radius of the heap of powder formed. It is calculated 
by the following formula- 
tan θ=h/r 
Where, θ = angle of repose,                                                                                                                           
h =height in cm,                                                                                                                                  
r = radius in cm. 
4. Carr’s Index30 
A simplex way of measurement of the free flow of powder. Carr’s index measures the propensity 
of powder to be compressed and the flow ability of powder. Carr’s index can be calculated from 
the bulk and tapped density by using following formula- 
Carr’s index=((Tapped density-Bulk density))/(Tapped density) X 100 
5. Hausner’s ratio30  
Hausner’s ratio also measure the propensity and the flow ability of powder. Hausner’s ratio can 
be calculated from the bulk and tapped density.Hausner ratio given by the equation-: 
Hausner’s ratio=(Tapped density)/(Bulk density) 
EVALUATION OF FAST DISSOLVING TABLETS 
1. Thickness
31
- 
Tablet thickness is an important characteristic and isexpressed in mm. The thickness and 
diameter of the tablets was determined using a micrometer screw gauge.  
2. Weight variation test
32
 – 
 For this test 20 tablets are generally selected randomly from the lot and weighted individually 
for checking weight variation. Weight variation specification as per I.P. is shown in table-: 
Table-3: weight variation and accepted % deviation. 
 
 
 
 
 
 
3. Hardness
32
- 
Average weight of tablet % Deviation 
80mg or less 10.0 
More than 80mg but less 
than 250mg 
7.5 
250mg or more 5.0 
 Force required to break a tablet in a diametric compression testis called hardness (crushing 
strength). Hardness is measured by using a Monsanto Hardness Tester. 
4. Friability
32
-  
Roche friabilator is used for the measurement of friability using 20 tablets. Twenty tablets are 
weighed and rotated at 25 rpm for 4 minutes (100 revolutions). The tablets were then reweighed 
after removal of fines   and the percentage of weight loss was calculated. 
% Friability=((Initial weight-final weight))/(Initial weight) X 100 
 5. Measurement of Tablet Porosity
33
-  
Porosity of tablet can be determined by using mercury penetration porosimeter. The tablet 
porosity (ε) can be calculated by using following equation, 
ε=(1-m )/(ρt V) X 100 
             Where, ρt = true density,   m and V = weight and volume of the tablet, respectively. 
6. Water absorption ratio
33 
A tablet is placed on the paper and the time required for complete wetting is determined by using 
following formula-  
Water absorption ratio=(Wb-Wa )/Wb X 100 
       Where, Wa = weight of tablet after absorption, Wb = weight of tablet before absorption. 
7. In-vitro disintegration time
34 
This test is performed on 6 tablets, by placing tablet into each tube (3 inches long and have 10 
mesh screen) of apparatus using the distilled water (used as disintegration medium) at a 
frequency of 28-32 cycle/minute and 37
0
C ± 2
0
C  and the time in second was noted when no 
lumps remaining in the apparatus. 
8. In-vitro dissolution study
35 
Dissolution study is carried out by using USP type-II apparatus. The dissolution test is performed 
using 900 ml of the dissolution medium at 50 rpm and 37°C ±0.5°C. 10 ml of aliquots were 
periodically withdrawn and the sample volume was replaced with an equal volume of fresh 
dissolution medium to maintain sink condition. The samples are analyzed spectrophotometrically 
at a particular wavelength. 
9. Stability studies
36
  
Stability testing of tablets is done to check whether it is a stable product or not and to check 
integrity of formulations during its shelf life. The formulation prepared should be packed in a 
special way, firstly the formulation is wrapped in a butter paper then aluminium foil is wrapped 
over it, then this is packed in an aluminium pouch and heat sealed. Storage conditions of 
formulation should be 45
o
C/ 75% RH. Formulations should be stored for 3 months. During the 
course of stability study triplicate samples should be taken at three sampling intervals i.e. 0, 1 
and 3 month, and tablets should be evaluated for physical changes and drug content. 
 
Table 4: List of marketed fast dissolving tablets 
S. N. Brand name  Active ingredient  Application 
1.  
Benadryl® Fastmelt®  
Diphenhydramine 
citrate 
Sinus pressure relief  
2.  Citalopram® ODT  Citalopram  Antidepressant 
3.  Claritin®, RediTabs®  Loratadine  Antihistamine 
4.  DuraSolv®, Alavert®  Loratadine  Allergy 
5.  Excedrin® QuickTabs  Acetaminophen  Pain reliever 
 6.  Feldene® Melt  Piroxicam  Rheumatoid arthritis 
7.  Gaster D®  Famotidine  Antiulcer 
8.  Imodium Instant Melts®  Loperamide HCL  Antidiarrhoeal 
9.  Kemstro™  Baclofen  Antispastic, analgesic 
10.  Klonopin®  Clonazepam  Anticonvulsant 
11.  Maxalt® -MLT  Rizatriptan benzoate  Migraine 
12.  
Metozolv ODT®  Metoclopramide  
Antiemetic, 
Gastroprokinetic agent 
13.  Nasea OD®  RamosetronHCl  Antiemetic 
14.  Nimulid MD®  Nimesulide  Pain reliever 
15.  NuLev®  Hyoscyaminesulfate  Antiulcer 
16.  Pepeid® ODT  Femotidene  Anti-ulcer  
17.  Propulsid® 
Quicksolv ® 
Cisapride Monohydrate  
Gastrointestinal 
prokinetic Agent 
18.  
Relivia®  
Tramadol 
Hydochloride  
Pain reliever 
19.  Remeron® Soltab®  Mirtazapine  Antidepression 
20.  Resperdal®, M-
TabTM®  
Resperidone  Schizophrenia 
21.  Tempra®Quiclets  Acetaminophen  Analgesic 
22.  
Triaminic® Softchews®  Various combination  
Pediatric cold 
cough,Allergy 
23.  Vimovo®  Naproxen  NSAID 
24.  Vometa® FT  Domperidone  Antiemetic, Prokinetic agent 
25.  ZubrinTM (Pet drug)  Tepoxelin  Canine NSAIDs  
26.  Zyperxa®  Olazepine  Psychotropic  
27.  ZelaparTM  Selegiline  Parkinson’s disease 
28.  Zofran® ODT  Ondansetron  Antiemetic 
29.  Zomig® ZMT  Zolmitriptan  Migraine 
 
CONCLUSION 
FDTs are innovative dosage forms specially designed to get disintegrated in saliva without the 
need of water, due to the porous structure of the tablet matrix or on the addition of 
superdisintegrants and/or effervescent excipients. 
Fast dissolving tablets have better patient compliancespecially geriatric and pediatric 
populations for and offer improved biopharmaceutical properties and efficacy and better safety 
when compared with conventional. The development of a fast-dissolving tablet also provides an 
opportunity for extension in the market place. Pharmaceutical marketing is another reason for the 
development of fast dissolving products.  Hence, patient demand and the availability of various 
technologies have increased the acceptance of Fast disintegrating tablets, which in turn prolongs 
the patent life of a drug.  There is need for improved manufacturing processes for fast dissolving 
tablets to make them mechanically strong, allowing ease of handling and packaging and with 
production costs similar to that of conventional tablet. 
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